LON:HLN Haleon (HLN) Share Forecast, Price & News GBX 334.70 -1.95 (-0.58%) (As of 04:29 PM ET) Add Compare Share Share Today's Range 333.45▼ 337.6050-Day Range 312.80▼ 337.8552-Week Range 263.15▼ 357.65Volume2.97 million shsAverage Volume13.28 million shsMarket Capitalization£30.89 billionP/E Ratio2,574.62Dividend Yield1.20%Price TargetGBX 338 ProfileProfileAnalyst RatingsChartCompetitorsDividendHeadlinesProfileAnalyst RatingsChartCompetitorsDividendHeadlines Haleon MarketRank™ ForecastAnalyst RatingHold2.14 Rating ScoreUpside/Downside0.5% UpsideGBX 338 Price TargetShort InterestN/ADividend StrengthWeakBased on Four FactorsSustainabilityN/ANews Sentiment0.42Based on 3 Articles This WeekInsider TradingN/AProj. Earnings GrowthN/ASee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.0.95 out of 5 stars 1.1 Analyst's Opinion Consensus RatingHaleon has received a consensus rating of Hold. The company's average rating score is 2.14, and is based on 2 buy ratings, 4 hold ratings, and 1 sell rating.Price Target Upside/DownsideAccording to analysts' consensus price target of GBX 338, Haleon has a forecasted upside of 0.5% from its current price of GBX 336.44.Amount of Analyst CoverageHaleon has received no research coverage in the past 90 days. Previous Next N/A Short Interest Short InterestThere is no current short interest data available for HLN. Previous Next 0.8 Dividend Strength Dividend YieldHaleon pays a meaningful dividend of 1.10%, higher than the bottom 25% of all stocks that pay dividends.Dividend GrowthHaleon does not have a long track record of dividend growth.Dividend CoverageThe dividend payout ratio of Haleon is 3,076.92%. Payout ratios above 75% are not desirable because they may not be sustainable. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for HLN. Previous Next 1.9 News and Social Media Coverage News SentimentHaleon has a news sentiment score of 0.42. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.54 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 3 news articles for Haleon this week, compared to 1 article on an average week.Search InterestOnly 1 people have searched for HLN on MarketBeat in the last 30 days. This is a decrease of -93% compared to the previous 30 days. Previous Next 1.7 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Haleon insiders have not sold or bought any company stock.Percentage Held by Insiders39.41% of the stock of Haleon is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by InstitutionsOnly 26.22% of the stock of Haleon is held by institutions. Previous Next 0.0 Earnings and Valuation Price to Earnings Ratio vs. the MarketThe P/E ratio of Haleon is 2,587.98, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 118.41.Price to Earnings Ratio vs. SectorThe P/E ratio of Haleon is 2,587.98, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 105.34.Price to Earnings Growth RatioHaleon has a PEG Ratio of 3.25. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioHaleon has a P/B Ratio of 1.89. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here About Haleon (LON:HLN) StockHaleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, minerals, and supplements. Its portfolio of brands includes Advil, Sensodyne, Panadol, Voltaren, Theraflu, Otrivin, Polident, parodontax, and Centrum. The company was formerly known as DRVW 2022 plc and changed its name to Haleon plc in February 2022. Haleon plc was incorporated in 2021 and is headquartered in Weybridge, the United Kingdom.Read More HLN Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart HLN Stock News HeadlinesSeptember 19, 2023 | americanbankingnews.comHaleon plc (LON:HLN) Given Average Rating of "Hold" by BrokeragesSeptember 16, 2023 | americanbankingnews.comHaleon (LON:HLN) Shares Up 0.4%September 22, 2023 | Chaikin Analytics (Ad)This is the #1 Stock to Buy for the AI Tidal WaveMarc Chaikin warned people about NVDA before its 2023 bull run - now he’s naming his next pick or the AI tidal wave. Learn more here.September 7, 2023 | msn.comThe Share Price Has The Flu, But Haleon Is As Healthy As An OxAugust 23, 2023 | seekingalpha.comHaleon plc goes ex-dividend tomorrowAugust 10, 2023 | finance.yahoo.comThose who invested in Haleon (LON:HLN) a year ago are up 18%August 2, 2023 | msn.comHaleon Lifts Annual Sales Forecasts, Says Pricing & Efficiencies Offset Inflationary PressuresAugust 2, 2023 | msn.comShould investors buy Haleon shares after the company raised its full-year guidance?September 22, 2023 | Chaikin Analytics (Ad)Buy This Stock for AI Tidal Wave (not NVDA)The internet boom made more millionaires than any tech - Microsoft’s CEO says AI has even more potential. Here’s the #1 stock to buy.August 2, 2023 | bloomberg.comHaleon Raises Revenue Forecast on Demand for Consumer HealthAugust 2, 2023 | proactiveinvestors.comHaleon upgrades guidance after strong first halfAugust 2, 2023 | reuters.comHaleon raises annual organic revenue growth forecast on steady demandAugust 1, 2023 | msn.comHaleon Share Price: Is it a Good Time to Buy This British Share Ahead of Tomorrow’s Earnings?August 1, 2023 | msn.comAn Under the Radar Healthcare Stock to Add to Your PortfolioAugust 1, 2023 | uk.movies.yahoo.comAre Haleon shares a ‘buy’ ahead of tomorrow’s earnings?July 22, 2023 | msn.comIf I’d put £1,000 in Haleon shares 1 year ago, here’s what I’d have now!July 15, 2023 | uk.movies.yahoo.comAre Haleon shares a long-term bargain?July 5, 2023 | seekingalpha.comHaleon exploring sale of nicotine gum business - reportJuly 5, 2023 | reuters.comGSK-spinoff Haleon exploring sale of Nicotine gum business, Bloomberg reportsJuly 5, 2023 | benzinga.comHaleon Contemplates Sale of Non-Core Businesses, Including Nicotinell Brand: A Strategy Shift Towards Core ProductsJuly 3, 2023 | msn.comGSK-spinoff Haleon exploring sale of Nicotine gum business - Bloomberg NewsJune 26, 2023 | msn.comIf I’d invested £1,000 in the Haleon shares spin-off, here’s how much I’d have nowJune 21, 2023 | msn.comHLN vs. SYK: Which Stock Should Value Investors Buy Now?June 15, 2023 | finance.yahoo.comWill Haleon plc (HLN) Have Stable Growth in the Future?June 8, 2023 | uk.style.yahoo.comUp 32%, are Haleon shares the best FTSE 100 buy in June?May 23, 2023 | msn.comHaleon and NatWest: Two FTSE 100 Shares with a “Perfect 10” on the Smart Score ToolMay 18, 2023 | finance.yahoo.comHLN or SYK: Which Is the Better Value Stock Right Now?See More Headlines Receive HLN Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Haleon and its competitors with MarketBeat's FREE daily newsletter. Email Address HLN Company Calendar Ex-Dividend for 10/5 Dividend8/24/2023Today9/21/2023Dividend Payable10/05/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeLON Industry Drug Manufacturers—Specialty & Generic Sub-IndustryN/A SectorMedical Current SymbolLON:HLN CUSIPN/A CIKN/A Webwww.haleon.com Phone44 1932 822000FaxN/AEmployees24,622Year FoundedN/APrice Target and Rating Average Stock Price ForecastGBX 338 High Stock Price ForecastGBX 387 Low Stock Price ForecastGBX 275 Forecasted Upside/Downside+0.4%Consensus RatingHold Rating Score (0-4)2.14 Research Coverage7 Analysts Profitability EPS (Most Recent Fiscal Year)GBX 0.13 Trailing P/E Ratio2,589.62 Forward P/E Ratio17.32 P/E Growth3.25Net Income£1.23 billion Net Margins10.78% Pretax MarginN/A Return on Equity5.99% Return on Assets3.95% Debt Debt-to-Equity Ratio60.84 Current Ratio0.84 Quick Ratio0.93 Sales & Book Value Annual Sales£11.41 billion Price / Sales2.72 Cash FlowGBX 15.33 per share Price / Cash Flow21.95 Book ValueGBX 178 per share Price / Book1.89Miscellaneous Outstanding Shares9,230,000,000Free FloatN/AMarket Cap£31.07 billion OptionableNot Optionable BetaN/A 7 Stocks to Buy And Hold ForeverClick the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising. Get This Free Report Key ExecutivesMr. Brian McNamara (Age 56)CEO & Exec. Director Comp: $2.35MMr. Tobias Hestler (Age 50)CFO & Exec. Director Comp: $999kMs. Amy LanducciChief Digital & Technology OfficerMr. Bjarne Philip Tellmann (Age 56)Gen. Counsel Ms. Tamara Rogers (Age 53)Chief Marketing Officer Ms. Mairead Nayager (Age 48)Chief HR Officer Mr. Bart Derde (Age 53)Chief Supply Chain Officer Mr. Filippo LanziPres of EMEA & LatAmMs. Teri Lyng (Age 60)Head of Transformation & Sustainability Ms. Jooyong Lee (Age 45)Head of Strategy & Office of the CEO More ExecutivesKey CompetitorsSmith & NephewLON:SNGSKLON:GSKHikma PharmaceuticalsLON:HIKIndiviorLON:INDVHUTCHMEDLON:HCMView All Competitors HLN Stock - Frequently Asked Questions Should I buy or sell Haleon stock right now? 7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Haleon in the last twelve months. There are currently 1 sell rating, 4 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" HLN shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in HLN, but not buy additional shares or sell existing shares. View HLN analyst ratings or view top-rated stocks. What is Haleon's stock price forecast for 2023? 7 Wall Street research analysts have issued twelve-month target prices for Haleon's stock. Their HLN share price forecasts range from GBX 275 to GBX 387. On average, they anticipate the company's stock price to reach GBX 338 in the next year. This suggests a possible upside of 0.4% from the stock's current price. View analysts price targets for HLN or view top-rated stocks among Wall Street analysts. How have HLN shares performed in 2023? Haleon's stock was trading at GBX 327.35 on January 1st, 2023. Since then, HLN shares have increased by 2.8% and is now trading at GBX 336.65. View the best growth stocks for 2023 here. How often does Haleon pay dividends? What is the dividend yield for Haleon? Haleon declared a dividend on Wednesday, August 2nd. Investors of record on Thursday, August 24th will be given a dividend of GBX 1.80 per share on Thursday, October 5th. This represents a yield of 0.55%. The ex-dividend date of this dividend is Thursday, August 24th. The official announcement can be seen at this link. Read our dividend analysis for HLN. Is Haleon a good dividend stock? Haleon (LON:HLN) pays an annual dividend of GBX 4 per share and currently has a dividend yield of 1.10%. The dividend payout ratio is 3,076.92%. Payout ratios above 75% are not desirable because they may not be sustainable. Read our dividend analysis for HLN. What is Haleon's stock symbol? Haleon trades on the London Stock Exchange (LON) under the ticker symbol "HLN." How do I buy shares of Haleon? Shares of HLN stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.Compare Top Brokerages Here. What is Haleon's stock price today? One share of HLN stock can currently be purchased for approximately GBX 336.65. How much money does Haleon make? Haleon (LON:HLN) has a market capitalization of £31.07 billion and generates £11.41 billion in revenue each year. The company earns £1.23 billion in net income (profit) each year or GBX 0.13 on an earnings per share basis. How many employees does Haleon have? The company employs 24,622 workers across the globe. How can I contact Haleon? Haleon's mailing address is The Heights Building 5, First Floor The Heights, Weybridge KT13 0NY, United Kingdom. The official website for the company is www.haleon.com. The company can be reached via phone at 44 1932 822000. This page (LON:HLN) was last updated on 9/22/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Haleon plc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.